EP2708225
DPI samsetning sem inniheldur súlfóalkýleter-sýklódextrín
Status:
EP Einkaleyfi útrunniðEP appl. date:
22.4.2005EP published:
26.12.2018EP application number:
13184888.9
EP translation filed:
25.3.2019Grant published:
15.4.2019EPO information:
European Patent Register
Max expiry date:
21.4.2025Expiry date:
21.4.2025
Title:
DPI Formulation Containing Sulfoalkyl Ether Cyclodextrin
Timeline
Today
22.4.2005EP application
26.12.2018EP Publication
25.3.2019Translation submitted
15.4.2019Registration published
21.4.2025Expires
Owner
Name:
CyDex Pharmaceuticals, Inc.Address:
3911 Sorrento Valley Boulevard Suite 110, 92121, San Diego, CA, US
Inventor
Name:
Pipkin, James DAddress:
Lawrence, KS, US
Name:
Mosher, Gerold L.Address:
Kansas City, MO, US
Name:
Hecker, Douglas BAddress:
Liberty, MO, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
564892 PDate:
23.4.2004Country:
US
Classification
Categories:
A61K 9/12, A61K 9/14, C08B 37/16
Annual fees
Number
Paid
Expires
Payer
Number: 15
Paid: 8.3.2019
Expires: 21.4.2020
Payer: Árnason Faktor
Number: 16
Paid: 10.3.2020
Expires: 21.4.2021
Payer: Árnason Faktor ehf.
Number: 17
Paid: 10.3.2021
Expires: 21.4.2022
Payer: Árnason Faktor ehf.
Number: 18
Paid: 10.3.2022
Expires: 21.4.2023
Payer: Árnason Faktor ehf.
Number: 19
Paid: 8.3.2023
Expires: 21.4.2024
Payer: Árnason Faktor ehf.
Number: 20
Paid: 24.4.2024
Expires: 21.4.2025
Payer: Árnason Faktor ehf.